Stock UniverseDerived research view · source repositories remain read-only

Eli Lilly and Company (LLY)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - General
Score Band
Very High
Selection Score
49.00
Global Rank
54
Market Cap
939.80B
Latest Close
1.13K
RS Composite
7.07% · G#890

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
14.82%
3M
14.44%
6M
9.84%
1Y
48.78%
3Y
169.13%
5Y
493.81%
10Y
1672.14%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 4.08M · 30-day average: 3.47M · Max drawdown over stored range: -34.48%

Research Snapshot

Relative Strength vs SPX

RS Composite7.07%
20D RS15.61%
60D RS4.38%
120D RS5.48%
Global RS Rank890 · 73.47% percentile
Qualified+ RS Rank336 · 73.29% percentile
Group ScopeQualified+
Primary RS Rank102 · 77.73% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank6 / 701
Primary Percentile99.29
Score Notesmarket-cap support, industry-tailwind, category-leader

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-3072.25Bn/an/a25.28B28.1426.90Bn/an/a898Mn/an/a34.99%37.23%n/a5.28B39.37B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$28.1440.2x$80.4414.1xn/an/a$29.9537.8x

Shares Diluted: 898M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue28318.428541.4341244504365179
Revenue Growth (YoY)15.398%0.787%19.56%31.998%44.704%
Gross Profit21345.321911.6270423662554127
Operating Income8272.78653.3103251704029696
Free Cash Flow6056.15731.479237608972
Free Cash Flow Per Share6.6436.3360.8774.1599.977
EPS (Diluted) GAAP6.126.95.811.7122.95
EPS Growth-9.867%12.745%-15.942%101.897%95.986%
EPS Non-GAAP
Gross Margin75.376%76.771%79.246%81.311%83.044%
Operating Margin29.213%30.318%30.257%37.831%45.561%
Profit Margin19.711%21.88%15.356%23.511%31.667%
Free Cash Flow Margin21.386%20.081%2.321%8.348%13.765%
Shares Outstanding (Diluted)911.681904.619903.3904.1899.3
Shares Change (YoY)-0.09%-0.775%-0.146%0.089%-0.531%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-3019.80Bn/an/an/a7.40B37.36%8.26895.90M5.28B39.37Bprocessed
2025 Q42026-02-1219.29Bn/an/an/a6.64B34.41%7.39898.10M7.27B40.87Bprocessed
2025 Q32025-10-3017.60Bn/an/an/a5.58B31.72%6.21898.80M9.91B40.87Bprocessed
2025 Q22025-08-0715.56Bn/an/an/a5.66B36.38%6.29899.80M3.55B34.18Bprocessed
2025 Q12025-05-0112.73Bn/an/an/a2.76B21.68%3.06900.60M3.22B34.50Bprocessed
2024 Q42025-02-1913.53Bn/an/an/a4.41B32.59%4.88903.04M3.42B28.53Bprocessed
2024 Q32024-10-3011.44Bn/an/an/a970.30M8.48%1.07905.00M3.52B29.05Bprocessed
2024 Q22024-08-0811.30Bn/an/an/a2.97B26.25%3.28904.20M3.36B23.73Bprocessed
2024 Q12024-04-308.77Bn/an/an/a2.24B25.58%2.48903.80M2.59B24.56Bprocessed
2023 Q42024-02-219.35Bn/an/an/a2.19B23.41%2.42903.84M2.93B18.32Bprocessed
2023 Q32023-11-029.50Bn/an/an/a-57.40M-0.60%-0.06899.80M2.49B17.92Bprocessed
2023 Q22023-08-088.31Bn/an/an/a1.76B21.21%1.95902.70M2.83B18.16Bprocessed
2023 Q12023-04-276.96Bn/an/an/a1.34B19.32%1.49903.30M3.67B18.88Bprocessed
2022 Q42023-02-227.30Bn/an/an/a1.94B26.54%2.14904.98M2.21B14.74Bprocessed
2022 Q32022-11-016.94Bn/an/an/a1.45B20.91%1.61903.80M2.74B14.14Bprocessed
2022 Q22022-08-046.49Bn/an/an/a952.50M14.68%1.05902.90M2.74B14.69Bprocessed
2022 Q12022-04-297.81Bn/an/an/a1.90B24.36%2.10906.40M2.57B15.15Bprocessed
2021 Q42022-02-238.00Bn/an/an/a1.73B21.58%1.89911.62M3.91B15.35Bprocessed
2021 Q32021-10-276.77Bn/an/an/a1.11B16.39%1.22910.80M3.83B15.52Bprocessed
2021 Q22021-08-036.74Bn/an/an/a1.39B20.63%1.53910.40M3.27B14.74Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.